Evogene Ltd.

EVGN· Nasdaq

Since Oct 3, 2025

Transactions: 3
Purchases: 3
Sales: 0
Purchase value: $692.78K
Sale value: $0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Recanati LeonDirector

Filed Aug 13, 2026Period of report Aug 11, 20260001178913-26-004095

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseAug 11, 2026	Ordinary Shares	460,000	$0.635	$292.10K	1,343,886	Direct

Filing footnotes · 2

F1There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
F2The options reported in this row vest equally on a quarterly basis (25% per quarter) such that they will be fully vested by the one-year anniversary of the August 18, 2025 grant date.

Open on SEC EDGAR

Recanati LeonDirector

Filed Aug 5, 2026Period of report Aug 4, 20260001178913-26-003859

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseAug 4, 2026	Ordinary Shares^F1	800,000	$0.50	$400.00K	883,886	Direct

Tarcic GabiChief Development Officer

Filed Aug 26, 2026Period of report Jun 4, 20260001178913-26-004259

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseJun 4, 2026	Ordinary Shares	1,129	$0.60	$677.40	1,129	Direct

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.